Advertisement
UK markets closed

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.80
    -0.56 (-0.67%)
     

  • GOLD FUTURES

    2,328.00
    -14.10 (-0.60%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,387.20
    -1,794.60 (-3.37%)
     

  • CMC Crypto 200

    1,384.17
    -39.93 (-2.80%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

BUZZ-SkyePharma: strong first-half boosts stock

Reuters - UK Focus

** The specialty pharmaceutical company's shares up 5.8 pct, making them top gainers on the FTSE Small Cap Index , after reporting strong H1 results and indicating a better-than-expected full year

** SkyePharma (LSE: SKP.L - news) reported a 19 pct rise in H1 revenue and said it expects continued substantial growth in revenues in 2015 compared with 2014

** 15 times daily avg trading volumes traded in first 30 mins

** Up to Tuesday's close, the stock had lost 20 pct YTD

** Finncap initiates coverage with "buy" recommendation and 351 p price target; says in absence of any value-enhancing M&A, sees 31 pct upside in one year

(Reuters Messaging: roshni.menon.thomsonreuters.com@reuters.net)